Jacques Pierre Moreau

Bionova Holding Corp. produces and distributes fruits & vegetables. Its affiliates have alliances and licensing agreements with agricultural companies, value-added producers and marketers, and biotechnology research groups. The company's brands include Master's Touch and FreshWorld Farms. Bionova Holding is located in Oakland, CA.

Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.

Wool Equities Ltd. develops, manufactures and distributes wool products. It has retail and distribution access in the U.S. The company was founded on August 29, 1997 and is headquartered in Palmerston North, New Zealand.

WellGen, Inc. develops products for inflammation-based diseases. The company was founded in 1997 and is headquartered in New York, NY.

Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT.

Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand.

Part of Genesis Research & Development Corp. Ltd., BioStore NZ Ltd. operates a pharmaceutical company. The company is based in Auckland, New Zealand.

Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY.

Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London.

SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA.

CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand.

ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom.

Part of AgResearch Ltd., Orico Ltd. engages in the research and development of biotechnology and muscle growth therapeutics in livestock. The company is based in Dunedin, New Zealand.

Part of AgResearch Ltd., Paraco Ltd. engages in the research and development of parasite technology for sheep. The company is based in Hamilton, New Zealand. Paraco was acquired by AgResearch Ltd. on August 05, 2008.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Keraplast Manufacturing provides personal care products in nutritional and medical areas. It builds blocks at a cellular level, giving the human body structure and order and also develops healthy tissues, including skin, hair and nails. The company is headquartered in Lincoln, New Zealand.

NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden.

Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany.

LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France.

CuroNZ Ltd. is a clinical stage neurotherapeutics company based in Auckland, New Zealand. The New Zealander company aims to improve the quality of life of severely neurologically affected children and adult patients by using a body and mind boosting drug therapy with a modified naturally occurring molecule named nrp2945. This molecule controls seizure activity with simultaneous comorbidities improvement profiles in young patients diagnosed with epileptic encephalopathy syndromes like Lennox-Gastaut syndrome and adults with drug-resistant temporal lobe epilepsy. CuroNZ has completed a successful phase I safety trial in healthy volunteers and a small phase II trial in patients with absence epilepsy.

PharmApprove LLC provides strategic regulatory and scientific communications consultancy services to the pharmaceutical and biotech industries. The firm offers both strategic and tactical support to companies facing high-profile, high stakes events and engagements anywhere along the road to approval and commercialization -including FDA Advisory Committee meetings. The company was founded by Pete Taft in 1999 and is headquartered in Lawrenceville, NJ.